Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Thomas Göhler1, Stefan Jäger, Gabriele Warnecke

  • 1Department of Tumor Virology, Heinrich-Pette-Institute Martinistrasse 52, 20251 Hamburg, Germany.

Nucleic Acids Research
|February 22, 2005
PubMed
Summary

Mutant p53 (mutp53) proteins bind selectively to non-B DNA structures, independent of sequence. This DNA structure-binding mechanism explains mutp53

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastoma.

Molecular therapy. Oncology·2026
Same author

Real-world progression-free survival and overall survival in patients with HR<sup>+</sup>/HER2<sup>-</sup> advanced breast cancer treated in first-line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study.

International journal of cancer·2026
Same author

Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.

International journal of cancer·2025
Same author

Linkage of Clinical Trial Data to Routinely Collected Data Sources: A Scoping Review.

JAMA network open·2025
Same author

High-Throughput Determination of Infectious Virus Titers by Kinetic Measurement of Infection-Induced Changes in Cell Morphology.

International journal of molecular sciences·2024

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Mutant p53 (mutp53) proteins modulate gene transcription despite losing sequence-specific DNA binding.
  • The molecular mechanisms underlying mutp53's transcriptional regulation remain unclear.
  • Previous research highlighted DNA structure's role in wild-type p53 (wtp53) binding.

Purpose of the Study:

  • To investigate the DNA-binding properties of mutp53 proteins.
  • To determine if mutp53 interacts with non-B DNA structures.
  • To elucidate the basis for mutp53's transcriptional activities.

Main Methods:

  • Analysis of mutp53 binding to non-B DNA mimicking oligonucleotides.
  • Employment of various DNA-binding assays.
  • Comparison of mutp53 binding with wtp53 binding characteristics.

Related Experiment Videos

Main Results:

  • Mutp53 proteins exhibit selective and high-affinity binding to non-B DNA structures.
  • Unlike wtp53, mutp53 DNA binding is dependent on DNA's stereo-specific configuration, not sequence.
  • This binding is independent of specific DNA sequences.

Conclusions:

  • Mutp53 DNA binding is primarily determined by DNA structure, not sequence.
  • DNA structure-selective binding of mutp53 likely underlies its interaction with MAR elements.
  • This mechanism provides a basis for mutp53-mediated transcriptional modulation.